2. Academic Validation
  3. Identification of a Highly Cooperative PROTAC Degrader Targeting GTP-Loaded KRAS(On) Alleles

Identification of a Highly Cooperative PROTAC Degrader Targeting GTP-Loaded KRAS(On) Alleles

  • J Am Chem Soc. 2025 Nov 12;147(45):41367-41378. doi: 10.1021/jacs.5c10354.
Vesna Vetma 1 2,  Ilaria Puoti 1,  Natalia K Karolak 1,  Sohini Chakraborti 1 2,  Emelyne Diers 2,  Enrico Girardi 3,  Shakil Khan 1 2,  Giorgia Kidd 1 2,  Katrin G Kropatsch 3,  Ross Mclennan 1 2,  Suzanne O'Connor 1 2,  Matthias Samwer 3,  Nicole Trainor 2,  Claire Whitworth 2,  Andre J Wijaya 1 2,  Jeff Y F Wong 1 2,  David Zollman 1 2,  William Farnaby 1 2,  Johannes Popow 3,  Alessio Ciulli 1 2,  Peter Ettmayer 3,  Kirsten McAulay 1
Affiliations

Affiliations

  • 1 Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, 1 James Lindsay Place, DD1 5JJ Dundee, Scotland, U.K.
  • 2 Division of Biological Chemistry and Drug Discovery, School of Life Sciences, James Black Centre, University of Dundee, DD1 5EH Dundee, Scotland, U.K.
  • 3 Boehringer Ingelheim RCV GmbH & Co KG, 1221 Vienna, Austria.
PMID: 41166656 DOI: 10.1021/jacs.5c10354
Abstract

Kirsten rat sarcoma viral oncogene homologue (KRAS) is a frequently mutated oncogene in multiple types of Cancer and is a high priority target for oncology drug development. There are many different KRAS mutations, including mutations that favor the GTP-loaded hydrolysis-incompetent "active" state of KRAS, KRAS(on), that can lead to tumorigenesis. However, small molecule interventions thus far have predominantly targeted single mutations of "inactive" GDP-loaded KRAS, KRAS(off), such as KRASG12C. Here, we address this gap through the development of heterobifunctional VHL-based PROTACs capable of engaging and degrading KRAS(on), thus addressing a wider range of KRAS mutations. By studying ternary complex affinity, stability, and binding modes using SPR and X-ray cocrystal structures, we identified PROTACs that exhibit high positive cooperativity in forming ternary complexes with VHL and GCP-loaded KRAS as representative of KRAS(on) variants. Degrader activity profiling in relevant Cancer cells supported the discovery of ACBI4, a PROTAC which forms a highly stable and cooperative ternary complex between VHL and GTP-bound KRAS and which potently degrades KRASG12R, leading to antiproliferative effect in KRAS mutant-driven Cancer cells. ACBI4 provides a new chemical tool for studying the impact of degrading KRAS(on) mutants, which is not possible with current pan-KRAS inhibitors or degraders.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z